OKEP Nov'15

1.

Name:

2.

Territory:

3.

Email Id:

4.

How many patients on Hemodialysis (HD) with some renal complications were included in Study?

(a) 33

(b) 63

(c) 66

(d) 36

5.

Renoque consists of Co-enzyme Q10 and this CoQ10 is also known as __________

(a) Ubiquinone

(b) Ubidecaquinone

(c) Ubidecarenone

(d) All of above

6.

Each patient was given _______of CoQ10 at the start of every dialysis session for 6 months.

(a) 10 mg/HD

(b) 100 mg/HD

(c) 150 mg/HD

(d) 200 mg/HD

7.

Ubiquinol, % of total CoQ10 after 6 months was________

(a) 80 to 85

(b) 75 to 80

(c) 65 to 70

(d) 90 to 100

8.

What was the duration of study?

(a) 6 months

(b) 16 months

(c) 9 months

(d) 8 months

9.

A CoQ10 deficiency could result from________

(a) Impaired CoQ10 synthesis due to nutritional deficiencies (such as vitamin B6 deficiency)

(b) A genetic or acquired defect in CoQ10 synthesis or utilization

(c) Increased tissue needs resulting from a particular illness.

(d) All of the Above

10.

RENOQUE is available as __________

(a) 160 mg Capsule for oral administration

(b) 180 mg Tablet for oral administration.

(c) 180 mg Capsule for oral administration.

(d) 160 mg Tablet for oral administration.

11.

Which deficiencies have been observed in patients with chronic renal failure?

(a) Antioxidant

(b) Vitamin

(c) Coenzyme Q10

(d) All